← Eichor
Condition: Anticoagulants And Bleeding Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anticoagulants And Bleeding Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Selective CT for Anticoagulated Head Injured Patients
Phase N/A · 7 location(s) · Dr. Kerstin de Wit · NCT05364749Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage
Phase 3 · 2 location(s) · Walton Centre NHS Foundation Trust · NCT06322953International Care Bundle Evaluation in Cerebral Hemorrhage Research
Phase 4 · 54 location(s) · Region Skane · NCT06429332Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT07441382Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06692504Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
NA · 1 location(s) · Centre intégré universitaire de santé et de services sociaux · NCT07089030Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs
Phase N/A · 7 location(s) · St. Antonius Hospital · NCT07309848Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Hepa
NA · 1 location(s) · University Hospital, Strasbourg, France · NCT06890312Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
NA · 4 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06386107Long-term Anticoagulation in a Patient With Severe Hemophilia A
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07314983Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chroni
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT04701749Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation
Phase N/A · 1 location(s) · University Hospital, Motol · NCT06868823STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for O
Phase 4 · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT06901466Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Phase 4 · 40 location(s) · Drahomir Aujesky · NCT04263038Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
Phase N/A · 2 location(s) · Masaryk University · NCT07166302Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT07183605Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06194617Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gast
Phase 4 · 45 location(s) · Duk-Woo Park, MD · NCT04416581Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
NA · 1 location(s) · Rambam Health Care Campus · NCT07384013What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Phase 4 · 20 location(s) · St. Antonius Hospital · NCT04436978Caudal Analgesia & Anticoagulated Patient
Phase N/A · 1 location(s) · Salem Anaesthesia Pain Clinic · NCT05946850Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
NA · 18 location(s) · University Hospital, Clermont-Ferrand · NCT05641142Thrombolysis in Factor Xa-inhibitors Trial
Phase 3 · 13 location(s) · Guri Hagberg · NCT06878066External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
Phase N/A · 16 location(s) · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT07418099COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2
Phase N/A · 33 location(s) · Mahidol University · NCT06396299Management of Gastrointestinal Bleeding Under Direct Oral Anticoagulants
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07333144Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial
Phase 4 · 1 location(s) · Clinical Urology and Epidemiology Working Group · NCT06523959Anticoagulation After GI Bleeding Pilot Study and Registry
NA · 2 location(s) · Ottawa Hospital Research Institute · NCT05290857CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
Phase N/A · 1 location(s) · National Medical Research Center for Therapy and Preventive · NCT07575867
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.